To further illustrate the molecular mechanism of MMP1 and RUNX2 in TNBC, we initially examined the expression pattern of RUNX2 and MMP1 in the SUM-149 and MDA-MB-231 triple negative breast cancer cell line and the MCF-7 non-triple negative breast cancer cell line. Here, MMP1 is linked to triple-negative breast carcinoma.